para-Ethoxyamphetamine

From Wikipedia, the free encyclopedia
  (Redirected from 4-Ethoxyamphetamine)
Jump to: navigation, search
para-Ethoxyamphetamine
4-EtOamph.png
Systematic (IUPAC) name
1-(4-ethoxyphenyl)propan-2-amine
Clinical data
Legal status
?
Identifiers
CAS number 129476-58-0 N
ATC code ?
PubChem CID 125379
ChemSpider 111573 YesY
ChEMBL CHEMBL161985 YesY
Chemical data
Formula C11H17NO 
Mol. mass 179.258 g/mol
 N (what is this?)  (verify)

para-Ethoxyamphetamine, also known as 4-ethoxyamphetamine (4-ETA), is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes which is closely related to the infamous para-methoxyamphetamine (PMA). para-Ethoxyamphetamine has similar effects to PMA in animal studies, although with slightly weaker stimulant effects.[1][2][3] Like PMA, it has prominent MAOI activity,[4] and is likely to have similar dangers associated with its use.

See also[edit]

References[edit]

  1. ^ Martin-Iverson MT, Yamada N, By AW, Lodge BA (December 1991). ""Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment". Journal of Psychiatry & Neuroscience : JPN 16 (5): 253–61. PMC 1188362. PMID 1686728. 
  2. ^ Corrigall WA, Robertson JM, Coen KM, Lodge BA (January 1992). "The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine". Pharmacology, Biochemistry, and Behavior 41 (1): 165–9. doi:10.1016/0091-3057(92)90077-S. PMID 1539067. 
  3. ^ Hegadoren KM, Greenshaw AJ, Baker GB, Martin-Iverson MT, Lodge B, Soin S (January 1994). "4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats". Journal of Psychiatry & Neuroscience : JPN 19 (1): 57–62. PMC 1188563. PMID 8148367. 
  4. ^ Martin-Iverson MT, Lodge BA (December 1991). "Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines". Canadian Journal of Physiology and Pharmacology 69 (12): 1825–32. doi:10.1139/y91-270. PMID 1802356.